Integral Diagnostics Limited's (ASX:IDX) Top Owners Are Retail Investors With 50% Stake, While 44% Is Held by Institutions
Express News | Mexican President Sheinbaum: We Are Going to Give an Integral Response to Tariffs After April 2
Integral Diagnostics Updates Dividend Distribution Details
Ecolomondo Engages Integral Wealth for Market Advisory
Vanguard Group Acquires Substantial Stake in Integral Diagnostics
Integral: Interim report.
Integral: Confirmation
Integral: Securities Report - 19th Term (2024/01/01 - 2024/12/31)
Is Integral Ad Science Holding Corp. (IAS) the Best Advertising Stock to Buy Now?
Continuing to rise, attempting to recover against the background of buy on dips, ETC.
Overview of the previous week from March 17 to March 21, Tokyo Stock Exchange Growth Index High: 672.42 Low: 657.81 Close: 667.1 compared to the previous week: 1.19% ↑ continued rise, trying to recover supported by bargain hunting and other factors. It showed a trend of attempting recovery supported by bargain buying. Among individual stocks, a portion of biotech-related stocks such as Perseus Proteomics <4882> and Sanbio <4592> showed movement. However, large Market Cap stocks such as Trial HD <141A> and Integral <5842>.
Oriental Rail Infrastructure Secures Order Worth INR18.9 Million
Integral Metals Commences Phase I Exploration at Woods Creek Project in Partnership With Big Rock Exploration
Delisting of Securities of Vicinity Motor Corp.; Bright Green Corporation; Smart for Life, Inc.; Focus Impact Acquisition Corp.; Cactus Acquisition Corp. 1; AltEnergy Acquisition Corp.; Lilium N.V.; APx Acquisition Corp. I; Integral Acquisition...
Integral Consulting and ScitoVation Announce Strategic Alliance to Advance Innovation in Health Risk Assessment
Integral Molecular Launches Paratope-PLUS, a CDR-Scanning Service to Support Robust Patent Claims and Antibody Engineering
Integral Metals Announces the Addition of John David Clark as an Advisor to the Company
Integral Ad Science Holding Corp. (IAS): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts
Silvus Technologies Appoints Aerospace and Defense Financial Executive Jeffrey Lassiter as Chief Financial Officer
Integral Molecular's Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors
Integral Diagnostics Raised to Buy From Neutral by Citigroup >IDX.AU